Please join our staff as we participate or present in the following oral and poster presentations at the 2016 ASTRO Annual Meeting
Future biomarker test could guide treatment, surveillance decisions
Survival for months or several years while delaying treatment is possible
Diagnosis shouldn’t lead to debt, bankruptcy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Treatment currently varies substantially
Findings may help predict radiotherapy outcomes
Targeting myosins and kinesins to block tumor proliferation
A new standard treatment option for advanced/metastatic cases
Yet insurance restricts its utility
Choice of testing ‘is becoming interesting’
Advertisement
Advertisement